Find Livoletide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Azp-531, Azp 531, 9vhd7j6363, 3-((3s,6s,9s,12s,15s,18s,21s,24s)-6,15-bis(3-amino-3-oxo-propyl)-12-(3-guanidinopropyl)-3-(hydroxymethyl)-18-(1h-imidazol-5-ylmethyl)-9-isopropyl-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazabicyclo(22.3.0)heptacosan-21-yl)propanoic acid, Livoletide [inn], Unii-9vhd7j6363
Molecular Formula
C40H63N15O13
Molecular Weight
962.0  g/mol
InChI Key
JXPWLIYXIWGWSA-CLBRJLNISA-N
FDA UNII
9VHD7J6363

Livoletide
Livoletide is under investigation in clinical trial NCT03790865 (Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome).
1 2D Structure

Livoletide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[(3S,6S,9S,12S,15S,18S,21S,24S)-6,15-bis(3-amino-3-oxopropyl)-12-[3-(diaminomethylideneamino)propyl]-3-(hydroxymethyl)-18-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20,23-octaoxo-9-propan-2-yl-1,4,7,10,13,16,19,22-octazabicyclo[22.3.0]heptacosan-21-yl]propanoic acid
2.1.2 InChI
InChI=1S/C40H63N15O13/c1-19(2)31-38(67)51-23(8-11-29(42)58)34(63)53-26(17-56)39(68)55-14-4-6-27(55)37(66)50-24(9-12-30(59)60)33(62)52-25(15-20-16-45-18-47-20)36(65)49-22(7-10-28(41)57)32(61)48-21(35(64)54-31)5-3-13-46-40(43)44/h16,18-19,21-27,31,56H,3-15,17H2,1-2H3,(H2,41,57)(H2,42,58)(H,45,47)(H,48,61)(H,49,65)(H,50,66)(H,51,67)(H,52,62)(H,53,63)(H,54,64)(H,59,60)(H4,43,44,46)/t21-,22-,23-,24-,25-,26-,27-,31-/m0/s1
2.1.3 InChI Key
JXPWLIYXIWGWSA-CLBRJLNISA-N
2.1.4 Canonical SMILES
CC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCC(=O)N)CC3=CN=CN3)CCC(=O)O)CO)CCC(=O)N
2.1.5 Isomeric SMILES
CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN=C(N)N)CCC(=O)N)CC3=CN=CN3)CCC(=O)O)CO)CCC(=O)N
2.2 Other Identifiers
2.2.1 UNII
9VHD7J6363
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Azp531

2. Cyclci Dag(6-13)

3. Cyclic Des-acyl Ghrelin (6-13)

2.3.2 Depositor-Supplied Synonyms

1. Azp-531

2. Azp 531

3. 9vhd7j6363

4. 3-((3s,6s,9s,12s,15s,18s,21s,24s)-6,15-bis(3-amino-3-oxo-propyl)-12-(3-guanidinopropyl)-3-(hydroxymethyl)-18-(1h-imidazol-5-ylmethyl)-9-isopropyl-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazabicyclo(22.3.0)heptacosan-21-yl)propanoic Acid

5. Livoletide [inn]

6. Unii-9vhd7j6363

7. Azp531

8. Chembl2029605

9. Gtpl10884

10. Cyclo(des-acyl Ghrelin(6-13))

11. Hy-p0231

12. Cs-7528

13. Db15188

14. Q27896244

15. Synthetic Cyclic 8 Amino Acid Analog Of Human Unacylated Ghrelin

16. Cyclo(l-arginyl-l-valyl-l-glutaminyl-l-seryl-l-prolyl-l-.alpha.-glutamyl-l-histidyl-l-glutaminyl)

17. Cyclo(l-arginyl-l-valyl-l-glutaminyl-l-seryl-l-prolyl-l-alpha-glutamyl-l-histidyl-l-glutaminyl)

2.4 Create Date
2012-07-09
3 Chemical and Physical Properties
Molecular Weight 962.0 g/mol
Molecular Formula C40H63N15O13
XLogP3-5.5
Hydrogen Bond Donor Count14
Hydrogen Bond Acceptor Count15
Rotatable Bond Count17
Exact Mass961.47297712 g/mol
Monoisotopic Mass961.47297712 g/mol
Topological Polar Surface Area461 Ų
Heavy Atom Count68
Formal Charge0
Complexity1900
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of Prader-Willi syndrome


ABOUT THIS PAGE

Looking for 1088543-62-7 / Livoletide API manufacturers, exporters & distributors?

Livoletide manufacturers, exporters & distributors 1

45

PharmaCompass offers a list of Livoletide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Livoletide manufacturer or Livoletide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Livoletide manufacturer or Livoletide supplier.

PharmaCompass also assists you with knowing the Livoletide API Price utilized in the formulation of products. Livoletide API Price is not always fixed or binding as the Livoletide Price is obtained through a variety of data sources. The Livoletide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Livoletide

Synonyms

Azp-531, Azp 531, 9vhd7j6363, 3-((3s,6s,9s,12s,15s,18s,21s,24s)-6,15-bis(3-amino-3-oxo-propyl)-12-(3-guanidinopropyl)-3-(hydroxymethyl)-18-(1h-imidazol-5-ylmethyl)-9-isopropyl-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazabicyclo(22.3.0)heptacosan-21-yl)propanoic acid, Livoletide [inn], Unii-9vhd7j6363

Cas Number

1088543-62-7

Unique Ingredient Identifier (UNII)

9VHD7J6363

About Livoletide

Livoletide is under investigation in clinical trial NCT03790865 (Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome).

Livoletide Manufacturers

A Livoletide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Livoletide, including repackagers and relabelers. The FDA regulates Livoletide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Livoletide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Livoletide Suppliers

A Livoletide supplier is an individual or a company that provides Livoletide active pharmaceutical ingredient (API) or Livoletide finished formulations upon request. The Livoletide suppliers may include Livoletide API manufacturers, exporters, distributors and traders.

Livoletide GMP

Livoletide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Livoletide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Livoletide GMP manufacturer or Livoletide GMP API supplier for your needs.

Livoletide CoA

A Livoletide CoA (Certificate of Analysis) is a formal document that attests to Livoletide's compliance with Livoletide specifications and serves as a tool for batch-level quality control.

Livoletide CoA mostly includes findings from lab analyses of a specific batch. For each Livoletide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Livoletide may be tested according to a variety of international standards, such as European Pharmacopoeia (Livoletide EP), Livoletide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Livoletide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty